Summary & Overview
CPT 15014: Skin Cell Suspension Autograft Preparation, Additional 25 sq cm
CPT code 15014 is an add–on code for preparation of a skin cell suspension autograft (SCSA), reported for each additional 25 square centimeters (or part thereof) beyond the initial 25 sq cm. This code supports granular billing for advanced autografting techniques that fragment and suspend autologous skin cells for application to larger or multiple wound areas. Nationally, accurate use of 15014 matters for consistent reimbursement, coding compliance, and tracking utilization of tissue-engineering procedures in wound care and reconstructive services.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication provides an overview of payer coverage patterns, coding and billing benchmarks, and clinical context for when SCSA preparation is reported as an add–on service.
Readers will learn how 15014 is defined and applied in practice, common billing considerations and modifiers (listed separately), typical sites of service, and where to find related codes and documentation expectations. The report also summarizes national policy updates and payer guidance relevant to autograft preparation and add–on coding to inform revenue cycle, compliance, and clinical documentation teams.
Billing Code Overview
CPT code 15014 describes an add–on service for preparation of a skin cell suspension autograft (SCSA). This code is billed for each additional 25 sq cm (or part thereof) after the first 25 sq cm when preparing SCSA material.
Service type: Graft preparation / tissue engineering procedure
Typical site of service: Operative suite or procedure room in an acute care hospital, ambulatory surgery center, or specialized wound care clinic
Clinical & Coding Specifications
Clinical Context
A 48-year-old patient with extensive full-thickness skin loss after a burn injury undergoes staged wound reconstruction. The surgical team performs preparation of a skin cell suspension autograft to accelerate epithelialization of large or irregular wounds. The initial operative session includes harvesting a small split-thickness skin specimen from a donor site, processing it to create a skin cell suspension, and applying an SCSA over the primary 25 sq cm area. When the treated area exceeds the initial 25 sq cm, additional portions of the wound are managed intraoperatively and billed with 15014 for each additional 25 sq cm (or part thereof).
Typical clinical workflow:
-
Preoperative assessment and documentation of wound size, depth, etiology, and informed consent.
-
Harvesting of a split-thickness skin sample in the operating room or procedure suite under appropriate anesthesia.
-
Preparation of the skin cell suspension using enzymatic/mechanical processes per device/manufacturer protocol.
-
Application of the suspension to the wound bed, securing as needed with dressings or adjunctive grafting techniques.
-
Postoperative wound care instructions and planned follow-up for graft take assessment and dressing changes.
Coding Specifications
| Modifier |
|---|